Senior insider sale
Chief Executive Officer at TERNS PHARMACEUTICALS, INC. — senior position signals high conviction
$6.36M
169.25K shares
What this filing means
BURROUGHS AMY L. plans to sell 169.25K shares of TERNS PHARMACEUTICALS, INC. valued at approximately $6.36M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/15/2026ACC: 0001950047-26-000467
DirectorOfficer· Chief Executive Officer
Since Feb 2026
169.25K
Shares to sell
$6.36M
Approx. market value
97.92K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
1/15/2026
97.92KTotal acquired97.92K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/15/2026 | Exercise of Stock Options Cash | 97.92K | — |
| Total | 97.92K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
71.34K
Market value
$2.72M
1/5/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
97.92K
Market value
$3.64M
1/15/2026
Total
Units
169.25K
Value
$6.36M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/5/2026 | 71.34K | $2.72M | — | Completed |
| Planned — Approximate Date | ||||
1/15/2026 | 97.92K | $3.64M | NASDAQ | Planned |
| Total | 169.25K | $6.36M | ||